Point72 Asset Management, L.P. 13D and 13G filings for OKYO Pharma Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:33 pm Sale | 2026-03-31 | 13G | OKYO PHARMA LTD SHS USD OKYO | Point72 Asset Management, L.P. | 0 0.000% | -4,058,445 (Position Closed) | Filing |
| 2026-02-18 5:42 pm Purchase | 2026-02-17 | 13G | OKYO PHARMA LTD SHS USD OKYO | Point72 Asset Management, L.P. | 4,058,445 7.900% | 4,058,445 (New Position) | Filing |